Background: Distal femur and proximal tibia replacements as limb-salvage procedures with good outcome parameters for patients with tumours have been broadly described. However, the overall midterm outcome in a mixed, heterogeneous patient collective is still unclear. Patients and Methods: We retrospectively analysed 59 consecutive patients (33 for primary and 26 for revision surgery) between 1998 and 2017. Indication for implantation was tumour (n=16), periprosthetic fracture (n=14), traumatic fracture (n=14), infection (n=10), aseptic loosening (n=3), and pathological fracture (n=2). The mean follow-up duration was 3 years. Clinical functions were evaluated by Toronto Extremity Salvage Score and Knee Society Score. Knee extension and flexion force were measured. Results: The overall survival rate of arthroplasties was 59% (n=35). Major complications were observed in 36 (61%) patients. During the follow-up period, 14 (24%) patients died. We recorded periprosthetic joint infection in 21 (36%) patients, recurrence of tumour in two (3%), and aseptic implant failure in three (5%). The mean Toronto Extremity Salvage Score was 66±33, and the mean Knee Society Score was 49±30. The mean extension force on the operated side was significantly reduced at 60å nd 180˚ compared to the healthy side (p=0.0151 and p=0.0411, respectively). Conclusion: Distal femur and proximal tibia replacements showed limited clinical function in a heterogeneous patient collective. Indication for implantation should be considered carefully.The overall numbers of mega-arthroplasties are increasing. Although clinical function and patient reported outcomes after primary total knee arthroplasty are well described, existing data on revision arthroplasty, such as replacement of the distal femur and proximal tibia, are rare. Indications for revision surgery/patient-specific mega-arthroplasty at the knee are: (i) Primary implantation such as arthroplasty in cases of large bony defects after tumour resection or primary complex fracture; and (ii) revision surgery after failed total knee arthroplasty in cases of aseptic and septic loosening, periprosthetic fracture, pseudarthrosis, or recurrent prosthetic instability (1-4). The incidence of periprosthetic fractures with large bone defects range between 0.3% and 5.5% after primary total knee arthroplasty and are seen in up to 30% cases after revision arthroplasty, with mortality rates as high as 46% (1, 5).At our clinic, we primarily use the Modular Universal Tumour and Revision System (MUTARS ® ) (Implantcast GmbH, Buxtehude, Germany) for large bony defects at the distal femur and proximal tibia, which is a well-established system (6). The stem is made of titanium alloy (TiAl6V4) in the cementless implant and of CoCrMo alloy in the cemented version (1). Although good leg-length alignment and good clinical function can be achieved, implantation is associated with high reoperation rates of 25-50% (1, 3, 5-7). The opportunity to return to daily living after distal femur/proximal tibial replacement is impaired ...